96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#602NOVEL ANTI-INFLAMMATORY PEPTIDE AND USE THEREOF
#603EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF
#604BIOLOGICAL PEPTIDE FOR TREATING LUNG DISEASES AND APPLICATION THEREOF
#605Composition Comprising Thermosensitive Gel and Oligopeptide, and Use Thereof
#606Immunogenic compounds for cancer therapy
#607IMMUNE CHECKPOINT INHIBITOR COMBINATIONS
#608ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#609NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#610Compositions comprising circular polyribonucleotides and uses thereof
#611METHODS AND PRODUCTS FOR IN VIVO ENZYME PROFILING
#612ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS
#613Peptide-HLA complexes and methods of producing same
#614NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#615Anti-tumour response to modified self-epitopes
#616EPITOPIC VACCINE FOR AFRICAN SWINE FEVER VIRUS
#617IL-2RGAMMA BINDING COMPOUNDS
#618ADAPTIVE RECOMBINANT NANOWORMS FROM GENETICALLY ENCODABLE STAR AMPHIPHILES
#619PEPTIDES TARGETING SHP2 AND USES THEREOF
#620PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF
#621CEACAM based antibacterial agents
#622PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#623COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES
#624COMPLEXES FOR GENE DELETION AND EDITING
#625METHODS FOR TREATING CANCER USING SPL-108 POLYPEPTIDE BASED ON TP53 MUTATIONAL STATUS
#626Method for treating non-small lung cancer with a population of activated T cells
#627COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT THEREOF, AND USE THEREOF
#628TROLOX-PEPTIDE CONJUGATE AND USE THEREOF
#629NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#630SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#631HOMING PEPTIDE-GUIDED DECORIN CONJUGATES FOR USE IN TREATING EPIDERMOLYSIS BULLOSA
#632COMPOSITIONS AND METHODS
#633POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF
#634Interference peptides as inhibitors of interactions related to AMPAR endocytosis
#635CDCA1-derived peptide and vaccine containing same
#636PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#637NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#638Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#639IMMUNE INDUCER CONTAINING POLYNUCLEOTIDE-PEPTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#640COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS
#641RAS INHIBITORY PEPTIDES AND USES THEREOF
#642RECOMBINANT MICROALGAE ABLE TO PRODUCE KTTKS PEPTIDES, POLYPEPTIDES, OR PROTEINS AND THEIR DERIVATIVES AND ASSOCIATED METHOD AND USES THEREOF
#643TAU AGGREGATION INHIBITORS
#644NEW SYNTHETIC METHODS USING NATIVE CHEMICAL LIGATION IN FLOW
#645MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#646MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#647EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF
#648NPP1 FUSION PROTEINS
#649Functional and therapeutic effects of PAR4 cleavage by cathepsin G
#650In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#651PEPTIDOMIMETIC MACROCYCLES
#652METHOD FOR SOLUBLE EXPRESSION AND PURIFICATION OF HYDROPHOBIN
#653NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#654PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#655NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#656NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#657High-activity memory-improving derivative peptide and use thereof
#658Motor
#659NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS
#660MELANOMA THERAPEUTICS
#661Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#662INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#663PEPTIDOMIMETICS AND METHOD OF SYNTHESIS THEREOF
#664METHOD FOR PREPARING AMG 416 (ETELCALCETIDE)
#665PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#666NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#667COMPOUND AND DIAGNOSTIC SYSTEM COMPRISING SAID COMPOUND FOR THE GUSTATORY DETECTION OF INFLAMMATIONS IN THE ORAL CAVITY
#668Compounds with Antimicrobial Properties
#669Personalized immunotherapy against several neuronal and brain tumors
#670NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#671ENHANCEMENT OF CD47 BLOCKADE THERAPY BY PROTEASOME INHIBITORS
#672NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#673Antimicrobial peptides
#674NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS
#675PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER
#676NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#677ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#678COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
#679COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION AND WOUND HEALING
#680IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES
#681PLASMIN-RESISTANT PEPTIDES FOR TREATING STROKE AND RELATED CONDITIONS
#682METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#683NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#684α-sheet polypeptides and their use
#685Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method
#686Antigenic tripeptides derived from subsp. s-type strains, derivatives and uses thereof
#687TECHNOLOGIES USEFUL FOR ASSESSING PERMEABILITY
#688NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#689NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#690Method for preparing etelcalcetide hydrochloride
#691NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#692Mitochondria-Targeted Polypeptide, Preparation Method thereof, and Use thereof
#693Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#694MILK-DERIVED POLYPEPTIDE DERIVATIVE, COMPOSITION AND METHOD FOR PREVENTING AND TREATING OBESITY
#695METHODS TO SPECIFICALLY PROFILE PROTEASE ACTIVITY AT LYMPH NODES
#696CAR-T cells targeting glioma stem cells for the treatment of glioblastoma multiforme
#697NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#698TEIPP PEPTIDE VARIANT AND USES THEREOF
#699PEPTIDES THAT ENHANCE NMDA RECEPTOR FUNCTION AND USE THEREOF
#700PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE
#701Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#702METHOD OF CHARACTERIZING THE BINDING CHARACTERISTICS BETWEEN A PEPTIDE OF INTEREST AND MHC MOLECULES
#703B*44 restricted peptides for use in immunotherapy against cancers and related methods
#704COMPOSITION AND METHOD FOR IN VIVO ASSAY OF OPIOID RECEPTORS
#705NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#706PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#707B*44 restricted peptides for use in immunotherapy against cancers and related methods
#708Peptide
#709HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#710B*44 restricted peptides for use in immunotherapy against cancers and related methods
#711B*44 restricted peptides for use in immunotherapy against cancers and related methods
#712PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#713COLLAGEN PRODUCTION
#714Peptides and compositions for inhibiting hair growth
#715ANTI-INFLAMMATORY AGENTS
#716COMPOUNDS AND MODULES FOR INHIBITION OF PRE-miR-21 AND THEIR USE IN TREATMENT OF CERTAIN CANCERS
#717COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY
#718Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#719BRONCHIAL EMBOLIZATION MATERIAL
#720PEPTIDE-HINGE-FREE FLEXIBLE ANTIBODY-LIKE MOLECULE
#721CYCLIC PEPTIDE COMPOUND CONTAINING PIPERAZIC ACID, METHOD OF PRODUCING SAME, AND USES OF SAME
#722Peptides with cell damage protection activity and liposomial formulations
#723Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#724PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS AND MEDICINE
#725ENDOCYTOSIS ROUTING SEQUENCE PEPTIDE FOR CELL DELIVERY SYSTEMS
#726Peptides and T cells for use in immunotherapeutic treatment of various cancers
#727Cyclin G1 inhibitors and related methods of treating cancer
#728DEGRADABLE MULTI-ARM POLYETHYLENE GLYCOL DERIVATIVE
#729CLEAVABLE PEPTIDES AND INSECTICIDAL AND NEMATICIDAL PROTEINS COMPRISING SAME
#730COMPOUNDS HAVING RD TARGETING MOTIFS AND METHODS OF USE THEREOF
#731METAL-BINDING PEPTIDE, AND USE THEREOF
#732CELL PENETRATING PEPTIDES AND USES THEREOF
#733Stapled and stitched polypeptides and uses thereof
#734Production and Purification Method for Polypeptide
#735Compositions and method for optimized peptide vaccines using residue optimization
#736A*03 restricted peptides for use in immunotherapy against cancers and related methods
#737IMMUNOGENIC PEPTIDE FRAGMENTS OF METALLOPROTEASE ADAMTS-7 AND USES THEREOF IN ANTI-ATHEROSCLEROSIS AND RELATED DISEASES
#738PEPTIDE, COMPOSITION, AND METHOD FOR TREATING, PREVENTING, OR AMELIORATING MOOD DISORDER
#739Peptoid, and its preparation method and use
#740Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#741NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS
#742PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS
#743A*03 restricted peptides for use in immunotherapy against cancers and related methods
#744Personalized immunotherapy against several neuronal and brain tumors
#745Personalized immunotherapy against several neuronal and brain tumors
#746METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
#747A SERIES OF INJECTABLE HYDROGELS SELF-ASSEMBLED FROM SHORT PEPTIDES FOR VARIOUS BIOMEDICAL APPLICATIONS
#748Peptides and combination thereof for use in the immunotherapy against cancers
#749Cell penetrating peptide
#750Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#751NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#752Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#753Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#754PEPTIDE PHARMACEUTICALS
#755SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS
#756CD200 inhibitors and methods of use thereof
#757STABILIZED PEPTIDE COMPOSITION
#758Isolated peptide, anti-cancer medicinal composition including the same and method of specifically reducing or inhibiting activities of cancer cells using the same
#759Bicyclic peptide ligands specific for P-selectin
#760Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#761ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#762INTERLEUKIN 15 FUSION PROTEIN FOR TUMOR TARGETING THERAPY
#763PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS
#764TARGETED PULMONARY DELIVERY COMPOSITIONS AND METHODS USING SAME
#765Peptides and T cells for use in immunotherapeutic treatment of various cancers
#766ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#767Peptides with Phytosanitary Activities
#768ANTI-INFLAMMATORY PEPTIDES, PHARMACEUTICAL COMPOSITION CONTAINING SUCH PEPTIDES, AND USES THEREOF
#769THERAPEUTIC PEPTIDES
#770THERAPEUTIC PEPTIDES
#771PROTEIN-WIDE MODIFICATION OF ASPARTATES AND GLUTAMATES
#772THERAPEUTIC PEPTIDES
#773LIPIDATED CATIONIC PEPTIDE-PEG COMPOSITIONS FOR NUCLEIC ACID DELIVERY
#774Peptides and T cells for use in immunotherapeutic treatment of various cancers
#775NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#776Cyclic peptide compound simulating natural product structure, and method for preparation thereof
#777COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#778Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#779IMMUNOTHERAPY FOR ANGIOGENIC DISEASE
#780PEPTIDES THAT BLOCK PRESENTATION OF ANTIGENIC ISLET PEPTIDES BY HLA-DQ8 AND METHODS FOR TREATING TYPE-1 DIABETES
#781TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
#782Cell penetrating peptides and uses thereof
#783Immunotherapy against several tumors including lung cancer
#784An improved process for the preparation of Etelcalcetide Hydrochloride
#785Immunostimulatory method
#786PEPTIDES HAVING INHIBITORY ACTIVITY ON NEURONAL EXOCYTOSIS
#787COMPOSITIONS AND METHODS FOR PROTEIN DETECTION
#788SYNTHETIC ANTIMICROBIAL PEPTIDES
#789LACTATE DEHYDROGENASE INHIBITOR POLYPEPTIDES FOR USE IN THE TREATMENT OF CANCER
#790Immunotherapy against several tumors including lung cancer
#791POLYPEPTIDE AND USE THEREOF
#792Peptides and combination of peptides for use in immunotherapy against various cancers
#793Peptides and combination of peptides for use in immunotherapy against various cancers
#794Use For JNK Inhibitor Molecules For Treatment Of Various Diseases
#795MODIFIED MULTIMERIC BICYCLIC PEPTIDE LIGANDS
#796HIGH YIELD PRODUCTION AND USE OF ENZYMATIC-EXCHANGEABLE PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SINGLE CHAIN TRIMER TETRAMER
#797IL-2RBETA BINDING COMPOUNDS
#798BONE REMODELING REGULATORY PEPTIDES AND APPLICATION THEREOF
#799NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#800A TEIXOBACTIN ANALOGUE AND USE THEREOF
#801Temporal traumatic brain injury biomarkers and methods of use thereof
#802ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#803Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#804Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#805P53 ACTIVATOR PEPTIDOMIMETIC MACROCYCLES
#806Peptide
#807IMMUNITY INDUCER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES
#808SELF-ASSEMBLING PEPTIDES AND HYDROGELS
#809Peptides and combination of peptides for use in immunotherapy against various cancers
#810Peptides and combination of peptides for use in immunotherapy against various cancers
#811Peptides and combination of peptides for use in immunotherapy against various cancers
#812Immunotherapy against several tumors including gastrointestinal and gastric cancer
#813CANNABINOID CONTAINING TARGETING LIPOSOMES
#814Polypeptide and use thereof
#815PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF
#816Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
#817Peptides and combination of peptides for use in immunotherapy against various cancers
#818Peptides and combination of peptides for use in immunotherapy against various cancers
#819Drug delivery methods and compositions
#820DPEP-1 BINDING AGENTS AND METHODS OF USE
#821Polymer agonists of mu opioid receptors
#822Peptides and combination of peptides for use in immunotherapy against various cancers
#823Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma
#824Peptides and T cells for use in immunotherapeutic treatment of various cancers
#825GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers
#826Antimicrobial compositions and methods of use thereof
#827Dietary peptides
#828Engineered muscle targeting compositions
#829Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#830Therapeutic peptides
#831Peptide compound and application thereof, and composition containing peptide compound
#832INHIBITORS OF IL-15 AND THEIR USE IN TREATING AUTOIMMUNE/INFLAMMATORY DISORDERS
#833Peptides and Compounds that Bind to Elongation Initiation Factor 4E
#834SIDEROPHORE-DIHYDROFOLATE REDUCTASE INHIBITOR CONJUGATE AND APPLICATION THEREOF
#835Peptide having activity of improving skin condition and use thereof
#836Proximity-based sortase-mediated protein purification and ligation
#837Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#838PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#839PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#840Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1)
#841NOROVIRUS-BINDING PEPTIDE
#842RESIN FILM FORMED OF SCAFFOLD MATERIAL FOR CELL CULTURE, CARRIER FOR CELL CULTURE AND CONTAINER FOR CELL CULTURE
#843COMPOSITIONS AND METHODS USEFUL IN TREATING BRAIN DISEASES
#844Treatments for Gastrointestinal Disorders
#845NOROVIRUS-BINDING PEPTIDE
#846Cyclic peptide analogs and conjugates thereof
#847Methods for efficient delivery of therapeutic molecules in vitro and in vivo
#848SYNTHETIC COMPOUND
#849Method for treating non-small lung cancer with a population of activated cells
#850Peptides and T cells for use in immunotherapeutic treatment of various cancers
#851NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#852METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#853Compositions and method of use for hair straightening and shaping
#854NOROVIRUS-BINDING PEPTIDE
#855TDP-43 mitochondrial localization inhibitor for the treatment of neurogenerative disease
#856PPR PROTEIN CAUSING LESS AGGREGATION AND USE OF THE SAME
#857VASCULAR CHOLESTEROL INHIBITORS AND USE THEREOF
#858PLATELET-FACILITATED DELIVERY OF THERAPEUTIC COMPOUNDS
#859Peptide for treating sepsis derived from Rv2626c protein of
#860Methods for Detecting A Mycobacterium Tuberculosis Infection
#861AAV9 affinity agents
#862Peptides and combination of peptides for use in immunotherapy against various tumors
#863METHOD OF TREATMENT
#864Peptide compound and application thereof, and composition containing peptide compound
#865DYNAMICS WITHIN SUPRAMOLECUAR IKVAV MATRICES ENHANCE FUNCTIONAL MATURATION OF HUMAN IPSCS-DERIVED NEURONS AND REGENERATION
#866MANUFACTURE OF DISULFIDE BONDED PEPTIDES
#867PEPTIDE EXHIBITING EXCELLENT ADHESION TO RESINS AND BIOCOMPATIBLE FUNCTIONAL MATERIAL USING SAME
#868PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF
#869Peptide, compositions and method for delivery of agents into cells and tissues
#870NOVEL OLIGOPEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING THE SAME AS AN ACTIVE INGREDIENT
#871Short synthetic peptides and their uses for treating retinal degenerative diseases and/or tissue injuries
#872Goggle imaging systems and methods
#873TARGETED ANTICOAGULANT
#874BK CHANNEL-MODULATING PEPTIDES AND THEIR USE
#875Immunotherapy against several tumors including lung cancer
#876PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#877DETECTION OF COLONIC NEOPLASIA IN VIVO USING NEAR-INFRARED PEPTIDE TARGETED AGAINST OVEREXPRESSED CMET
#878HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN PRESENTING CELL
#879Tissue occluding agent comprising an ieikieikieiki peptide
#880PEPTIDE-DERIVED THERAPEUTICS TARGETING SET8 FOR THE TREATMENT OF CANCER
#881Amino deprotection using 3-(diethylamino)propylamine
#882PEPTIDE-DERIVED THERAPEUTICS TARGETING KDM5C FOR THE TREATMENT OF CANCER
#883AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#884COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES
#885Peptide having activities of skin whitening and uses thereof
#886FERRITIN NANOCAGE FOR MULTI-DISPLAYING TRAIL TRIMER AND CANCER-TARGETING PEPTIDE AND USE THEREOF AS ANTICANCER AGENT
#887CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF
#888METHOD FOR MODIFYING AMINO GROUP IN MOLECULE WITH THE ZOLINIUM AND USE THEREOF
#889PEPTIDE AND USE THEREOF
#890Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma
#891Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#892Peptides and T cells for use in immunotherapeutic treatment of various cancers
#893Chloride salt of TAT-NR2B9C
#894EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS
#895Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#896Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers
#897SPLIT PHOTOACTIVE YELLOW PROTEIN COMPLEMENTATION SYSTEM AND USES THEREOF
#898Angiotensin I-converting enzyme (ACE) inhibitory peptides
#899Peptide having activities of skin whitening and uses thereof
#900NRP-1 BINDING INHIBITORY PEPTIDES AND USES THEREOF